SAGE THERAPEUTICS
SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.
SAGE THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sagerx.com
Total Employee:
501+
Status:
Active
Contact:
6172998379
Email Addresses:
[email protected]
Total Funding:
2.7 B USD
Technology used in webpage:
LetsEncrypt Apple Mobile Web Clips Icon WordPress Sitelinks Search Box Organization Schema IPv6 Yoast WordPress SEO Plugin Google Maps JsDelivr Yoast SEO Premium
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Soterix Medical
Soterix Medical develops devices and accessories based on neuromodulation and brain stimulation technologies.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Biogen Idec
Biogen Idec investment in Post-IPO Equity - SAGE Therapeutics
Foresite Capital
Foresite Capital investment in Series C - SAGE Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series C - SAGE Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - SAGE Therapeutics
OrbiMed
OrbiMed investment in Series C - SAGE Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series C - SAGE Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series B - SAGE Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - SAGE Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series A - SAGE Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-21 | Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer |
Official Site Inspections
http://www.sagerx.com Semrush global rank: 1.68 M Semrush visits lastest month: 14.6 K
- Host name: aea60fdf1a932c684.awsglobalaccelerator.com
- IP address: 76.223.51.166
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "SAGE Therapeutics"
Biopharmaceutical Company for Brain Health Medicine - sagerx.com
Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs. See details»
About Us | Sage Therapeutics
Sage Therapeutics is on a mission to pioneer solutions to deliver life-changing brain health medicines, so that every person can thrive. We believe that it is time to usher in a new era in … See details»
Enjoy the Journey | Sage Therapeutics Careers
Enjoy the Journey It’s time to discover your future with Sage… We are Sage Therapeutics, and our vision is to fearlessly lead the way to create a world with better brain health. See details»
Grants - Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs. See details»
Supernus Pharmaceuticals to Acquire Sage Therapeutics, …
Jun 16, 2025 The Investor Relations website contains information about Sage Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. See details»
Sponsorships - Funding & Giving | Sage Therapeutics
Within 60 days of the request end date, recipient organizations must complete a reconciliation confirming receipt of funds and attesting that Sage received the tangible benefits described in … See details»
SAGE Therapeutics - Crunchbase Company Profile & Funding
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders. See details»
myworkdayjobs.com
Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new … See details»
Sage Therapeutics Announces Strategic Reorganization to …
Oct 17, 2024 CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Oct. 17, 2024-- Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced a strategic reorganization of its business operations to … See details»
This is Sage | Sage Therapeutics Careers - careers.sagerx.com
Enjoy the Journey At Sage, we believe that life is more than just a destination. We're concerned with the journey - and we care deeply about everyone contributing to and benefitting from our … See details»
Biopharmaceutical Company for Brain Health Medicine …
Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs. See details»
SAGE THERAPEUTICS INC._10K_2025_V1 - investor.sagerx.com
Apr 25, 2025 Delaware (State or Other Jurisdiction of Incorporation or Organization) 27-4486580 (I.R.S. Employer Identification No.) 55 Cambridge Parkway Cambridge, Massachusetts 02142 … See details»
Corporate Membership - Funding & Giving | Sage Therapeutics
Corporate Membership Sage provides funding to support an organization in exchange for yearly corporate benefits. Opportunities may include: Sage actively participating with leadership or … See details»
FAQs - Funding & Giving | Sage Therapeutics - sagerx.com
The organization must attach the following information in the Sage Funding & Giving portal: Detailed report of the initiative Additional outcomes, including an analysis of learner change … See details»
Sagean Stories - Sage Therapeutics Careers
Chris Commercial Finding out what Chris and the team at Sage is looking for as we grow our Commercial organization. See details»
This is Sage | Sage Therapeutics Careers
We are Sage Therapeutics, and we're on a fiercely committed journey to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. See details»
Benefits - Sage Therapeutics Careers
Medical Insurance Our programs ensure you have extensive coverage. We have two Preferred Provider Organization (PPO) medical plan options to choose from to help you with whatever … See details»
Diversity, Equity & Inclusion at Sage Therapeutics
Sage Therapeutics is focused on leveraging science and a relentless commitment to patients to help improve the lives of millions of people. We see the brain differently, which propels us to … See details»
Taking Action To Address the Brain Health Pandemic
Regardless of which exact providers you choose for your organization, ensuring that all of your employees have access to exceptional care is an imperative start to them being able to do … See details»
Form 4 for Quirk Michael C filed 06/26/2025 - investor.sagerx.com
I, the undersigned, hereby authorize and designate Greg Shiferman (Senior Vice President, General Counsel, and Secretary) and Brandon Marsh (Executive Director, Corporate Counsel, … See details»